C
West Pharmaceutical Services, Inc. WST
$230.11 $6.382.85%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
52-Week Range
P/E (TTM)
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Net Income 130.10M 136.00M 111.30M 115.30M 137.00M
Total Depreciation and Amortization 40.70M 40.20M 38.90M 35.60M 35.90M
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -4.20M 4.00M 700.00K 1.90M 39.30M
Change in Net Operating Assets 23.50M -100.00K 14.10M -34.60M 26.90M
Cash from Operations 190.10M 180.10M 165.00M 118.20M 239.10M
Capital Expenditure -104.90M -81.30M -100.20M -90.60M -108.70M
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 100.00K -800.00K -1.00M -- -100.00K
Cash from Investing -104.80M -82.10M -101.20M -90.60M -108.80M
Total Debt Issued 0.00 129.70M 35.00M -- --
Total Debt Repaid -100.00K -133.20M -58.40M -600.00K -700.00K
Issuance of Common Stock 3.10M 6.00M 6.80M 16.80M 3.10M
Repurchase of Common Stock -54.60M -52.40M -187.20M -272.40M -177.10M
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -15.30M -14.50M -14.60M -14.70M -14.80M
Other Financing Activities -2.00M -- 100.00K -100.00K --
Cash from Financing -68.90M -64.40M -218.30M -271.00M -189.50M
Foreign Exchange rate Adjustments -22.70M 11.10M -1.10M -8.70M 14.50M
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -6.30M 44.70M -155.60M -252.10M -44.70M
Weiss Ratings